1Hegazy MA, Hegazi RA, Elshafei MA, et al. Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma. World J Surg Oncol, 2005,3 (1) :57-64
2Fagotti A, Fanfani F, Ludovisi M, et al. Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study. Gynecol Oncol, 2005, 96 (3):729-735
3Angioli R, Palaia I, Inllo MA. Diagnostic open laparoscopy in the management of advanced ovarian cancer, Gynecol Oncol, 2006,100(3):455-461
4Deffieux X, Castaigne D, Pomel C. Role of laparoscopy to evaluate candidates for complete cytoreduction in advanced stages of epithelial ovarian cancer, Int J Gynecol Cancer, 2006,16(s1):35-40
5Giannopoulos T, Butler-Manuel S, Taylor A, et al. Clinical outcomes of neoadjuvant chemotherapy and primary debulking surgery in advanced ovarian carcinoma.Eur J Gynaecol Oncol, 2006, 27( 1 ):25-28
6Lee SJ, Kim BG, Lee JW, et al. Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery. J Obstet Gynecol Res, 2006, 32 ( 1 ):90-106
7Pectasides D, Farmakis D, Koumarianou A, et al. The role of neoadjuvant chemotherapy in the treatment of advanced ovarian cancer, Oncology,2005,68( 1 ):64-70
8Vergote I, De Wever I, Decloedt J, et al. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian carcinoma.Semin Oncol, 2000, 27[3 Suppl 7]: 31-36
9Bristow RE, Duska LR, Lambrou NC, et al. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer, 2000,89 (7) : 1532-1540
10Vergote I, Marquette S, Amant F, el al. Port-site metastases after open laparoseopy: a study in 173 patients with advanced ovarian carcinoma. Int J Gynecol Cancer, 2005,15 (5) :776-779
10Pectasides D, Farmakis D,Koumarianou A,et al.The role of neoadjuvantchemotherapy in the treatment of advanced ovarian cancer[J].Oncology, 2005,68( 1 ) : 64 - 70.
